SRC and neoplasm: Further investigations indicated that compound 3k could be functioned as a tumor angiogenesis inhibitor mainly by the suppression of angiogenesis signaling pathways, such as ERK, JNK and FAK-Src etc. Therefore this series of new compounds may be effective in developing novel strategies for future cancer treatment.